Learning

If you have Hashimoto's, you probably already know something isn't fully adding up.

Even when everything on paper looks right — labs in range, medication dialed in, protocols followed carefully — the tiredness stays. The brain fog stays. The weight resistance stays. The sense that your body is still working against you stays.

You have been paying attention. You are not imagining it.

Standard Hashimoto's care addresses one specific piece of the picture. It replaces the thyroid hormone your thyroid isn't producing enough of anymore. That matters, and it's necessary. 

But it doesn't address the signaling infrastructure that determines how your body actually uses that hormone — or the immune dysregulation that drove the autoimmunity in the first place.

There is a piece of Hashimoto's that has been in the peer-reviewed literature for over a decade without making its way into most standard care conversations. It has to do with a hormone you may not have connected to your thyroid diagnosis at all.

Your leptin signaling and your thyroid function are more connected than standard care usually addresses.

Hashimoto's thyroiditis is an autoimmune condition where the immune system produces antibodies against thyroid tissue, gradually reducing the thyroid's ability to produce hormone. Standard diagnosis involves elevated anti-TPO or anti-thyroglobulin antibodies, elevated TSH, and often reduced T4/T3.

You already know this if you're reading this. 

What you may not know is what specifically drives the immune imbalance that produces those antibodies — and why leptin plays a much larger role in that process than mainstream discussion typically acknowledges.

Most people first encounter leptin as "the satiety hormone" or "the hormone your fat cells make to tell your brain you're full." That framing is technically accurate but wildly incomplete.

Leptin is a signaling hormone that operates across multiple systems simultaneously. It regulates energy balance, yes. It also directly regulates immune function through effects on T cell differentiation. It regulates thyroid axis function through direct action on the hypothalamus. It affects mitochondrial energy production. It modulates inflammatory pathways throughout the body.

When leptin signaling is functional, all of those systems have accurate information to work with. When leptin signaling is dysfunctional — through leptin resistance, chronic inflammation, or metabolic-inflammatory conditions that disrupt hypothalamic sensitivity — all of those systems are operating with degraded information.

Which brings us to Hashimoto's specifically.

The specific immune dysregulation that produces Hashimoto's involves an imbalance between two populations of immune cells: Th17 cells (which promote inflammation and autoimmune activity) and Treg cells (which regulate immune tolerance and prevent inappropriate autoimmune responses). 

In Hashimoto's, Th17 cells are elevated and Treg cells are suppressed. That imbalance is what drives the sustained autoimmune attack on thyroid tissue.

Research has directly connected leptin signaling to this specific imbalance.

A 2012 study in Clinical and Experimental Immunology (Wang et al.) demonstrated that T cell-derived leptin contributes to increased frequency of Th17 cells in female patients with Hashimoto's thyroiditis. In other words, leptin isn't just associated with Hashimoto's — it's mechanistically involved in driving the specific immune imbalance that produces the condition.

A 2022 study in Frontiers in Endocrinology took this further. Researchers using a mouse model of experimental autoimmune thyroiditis found that a leptin receptor antagonist reduced thyroid follicle destruction, reduced inflammatory cell infiltration, reduced autoimmune antibody levels, promoted Treg cell differentiation, and inhibited Th17 cell differentiation. The researchers concluded that "interfering with the leptin signaling pathway may be a novel approach to treating and ameliorating Hashimoto's thyroiditis."

This isn't fringe research. This is peer-reviewed endocrinology, published in mainstream journals, showing that leptin signaling is upstream of the immune dysregulation that produces Hashimoto's.

Which means the immune imbalance you've been told is "just what your body does" may actually be downstream of a signaling problem that could be addressed.

Here's another piece that most standard Hashimoto's care doesn't address.

Your thyroid produces primarily T4, which is a prohormone. To actually affect your cells, T4 has to be converted to T3, the active form. This conversion happens throughout the body via enzymes called deiodinases — particularly D1 (in liver, kidney, thyroid, pituitary) and D2 (in hypothalamus, pituitary, skeletal muscle, brown adipose tissue).

Research by Cettour-Rose and colleagues demonstrated that leptin resistance suppresses D1 deiodinase activity, decreasing T4-to-T3 conversion. In the presence of elevated leptin — which is common in metabolic-inflammatory conditions including many Hashimoto's cases — there is reduction of cellular T3 and suppression of TSH.

This has an important clinical implication that most standard care doesn't address: if your leptin signaling is dysfunctional, your labs can look adequate while your cells are actually receiving inadequate T3. The T4 is present. The TSH looks acceptable. But the conversion to active hormone at the cellular level is impaired. Your cells are, functionally, hypothyroid — even though your bloodwork says otherwise.

This is one of the mechanisms behind the exhausting "my labs are normal but I feel terrible" experience that so many Hashimoto's patients live with for years.

There's one more layer. Leptin directly regulates thyroid axis function at the hypothalamic level.

Sufficient leptin signaling is required to maintain TRH expression in the hypothalamic paraventricular nucleus. TRH signals TSH production. TSH signals thyroid hormone production. Without functional leptin signaling to the hypothalamus, the entire thyroid axis has degraded information flowing through it.

A comprehensive 2020 review in the International Journal of Endocrinology (Baranowska-Bik) synthesized much of this research, concluding that leptin resistance may contribute to autoimmunity in susceptible individuals through inflammatory signaling that operates independently of thyroid function itself. 

Regulation of inflammasome-derived cytokines becomes, in their words, "an important step in controlling the trigger of thyroid autoimmunity."

Read that sentence again if it landed.
 
Regulating the inflammatory signaling — much of which flows through leptin pathways — may be a key step in addressing the underlying trigger of thyroid autoimmunity itself. Not just managing symptoms. Not just replacing what the damaged thyroid can't produce. Addressing what may have been driving the autoimmunity in the first place.

This is the piece that has been missing from most standard Hashimoto's care conversations.

If you've been managing Hashimoto's for any length of time, some patterns probably feel familiar.

The morning fatigue that doesn't lift no matter how much you sleep. The 3pm crash that requires caffeine you'd rather not depend on. The brain fog that makes it hard to hold a conversation or focus on work. 

The weight that won't respond to reasonable dietary changes. The temperature regulation that never quite feels right. The mood shifts that seem disproportionate to what's happening in your life.

You may have been told these are just symptoms of Hashimoto's that you'll need to learn to manage.

They may actually be symptoms of signaling infrastructure that isn't functioning properly — infrastructure that thyroid medication doesn't address, because thyroid medication addresses hormone replacement rather than signaling restoration.

When leptin signaling is working properly, your cells receive accurate information about energy status. Your immune system receives accurate signals about when to activate and when to stand down. Your hypothalamus receives accurate signals about metabolic status. Your mitochondria receive the support they need to produce cellular energy efficiently. Your inflammatory pathways stay regulated rather than chronically elevated.

When leptin signaling is dysfunctional, all of those systems are operating with degraded information. Your cells don't know how much energy you actually have. Your immune system doesn't know when to modulate its response. Your hypothalamus can't properly regulate your thyroid axis. Your mitochondria don't get the support they need. Your inflammatory pathways stay chronically elevated.

Thyroid medication doesn't fix that. It gives you T4 to replace what your damaged thyroid can't produce. But it doesn't restore the signaling infrastructure that determines how effectively your body uses that T4 or how well your immune system regulates itself.

That's why so many people on adequate thyroid medication still feel exhausted, foggy, and out of balance. The medication is doing exactly what it's designed to do. The signaling infrastructure that determines whether that medication actually improves how you feel is a completely different piece.

There's one more aspect of the Hashimoto's experience that deserves its own attention, because almost nobody is talking about it accurately.

Hashimoto's brain fog is one of the most common and most under-addressed symptoms of the condition. Standard care essentially treats it as an inconvenience that comes with hypothyroidism — something you'll notice, something you'll adapt to, but not something that has a clear intervention beyond "get your thyroid levels right."

But brain fog isn't just about thyroid hormone levels. It's about your brain's ability to filter incoming sensory information and prioritize what matters — a neurological function called sensory gating.

Sensory gating is the brain's real-time sorting mechanism. 

Every moment of every day, your brain is receiving massive amounts of sensory input: sounds, visual information, internal body signals, thoughts, emotions, memories. Sensory gating is what determines which of those signals reach conscious attention and which stay in the background. 

When sensory gating works well, you can focus on a conversation while background music plays without feeling overwhelmed. When it doesn't work well, everything competes for attention simultaneously, and cognitive function degrades under the load.

Impaired sensory gating shows up as brain fog, difficulty concentrating, feeling overwhelmed by normal sensory input, needing silence to focus, avoiding crowds or busy environments, feeling "wired but tired," and struggling with tasks that require sustained attention.

Every one of these experiences is common in Hashimoto's. Not because Hashimoto's directly damages sensory gating circuits, but because the same metabolic-inflammatory dysfunction that drives Hashimoto's also impairs the neurological infrastructure sensory gating depends on. 

Chronic inflammation dampens thalamic filtering. Mitochondrial dysfunction reduces the energy available for high-demand filtering circuits. Neurotransmitter cofactor depletion affects inhibitory signaling that sensory gating requires.

Restoring the underlying metabolic-inflammatory infrastructure has a cascading effect on sensory gating capacity. People often discover restored capacity for sensory input they'd been unconsciously avoiding — enjoying music while working, tolerating background conversation without feeling drained, engaging in busy environments without cognitive collapse afterward.

If you have Hashimoto's and you've built your life around avoiding stimulation without realizing you were doing it — if you've stopped going to concerts, stopped playing music while you work, stopped seeking out sensory-rich experiences you used to love — that adaptation may not be your personality. It may be sensory gating capacity that has been compromised by the same infrastructure dysfunction affecting your thyroid.

This is another piece that thyroid medication alone doesn't address.

LeptinFX was built to support the leptin signaling infrastructure your body uses to regulate immune balance, cellular energy, and metabolic function.

It is not thyroid medication. It does not treat Hashimoto's. It does not replace any thyroid protocol you're already following.

What it does is support the underlying signaling systems that thyroid medication doesn't address — the leptin pathways that affect immune regulation, the cellular energy infrastructure that determines how well your cells use available T3, the metabolic signaling that supports whole-system balance, the mitochondrial function that underlies sensory processing capacity.

Whatever you are already doing for your thyroid — continue doing it. Work with your care team. Take your medication as prescribed. Follow the protocols you have found that work for you.

This is the piece that has been missing from that picture.

You have been paying attention. You are not imagining it.

The exhaustion you've been carrying may not be your thyroid failing. It may be signaling infrastructure that hasn't been addressed. The brain fog may not be something you need to learn to live with. It may be sensory gating capacity that could be restored. The sense that your body has been working against you may not be your body attacking itself so much as your body's signaling systems operating with degraded information.

Standard Hashimoto's care addresses one specific piece of a much larger picture. That piece matters. Continue with it. But it isn't the whole picture.

Your body has been trying to tell you something. Your body's phone has been ringing. LeptinFX helps you answer it.

You know what your body has been telling you.